Specialty Medicines - Respiratory

Actavis Indonesia is committed to providing high-quality treatments for people who suffer from respiratory diseases, including asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD), and cough therapy. Our innovative approach to respiratory care is centered on optimizing therapies through novel delivery systems and medicines that are designed to address patient needs.

Actavis Indonesia is focused on developing and providing treatment options that address two major issues within the current treatment landscape for respiratory diseases: 1) treatment adherence and compliance, and 2) treating asthma that remains uncontrolled despite the use of standard care therapy.

In the treatment of asthma, the goal is to maintain asthma control so people with asthma can preserve good lung function, exhibit fewer symptoms, and experience fewer asthma attacks.

Actavis Indonesia delivers a range of respiratory medicines today, including controller and rescue therapy. We are also committed to the development of new treatment options. Actavis Indonesia’s focus is on combining our integrated strengths in specialty medicines (including both small molecules and biologics), device platforms, and generics.

In addition to our currently available medicines, Actavis Indonesia has a broad pipeline of treatment options currently in development with the goal of further enhancing our product offerings and addressing unmet needs within the respiratory community.